chr1-205915163-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000367135.8(SLC26A9):c.*194G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,460,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
SLC26A9
ENST00000367135.8 3_prime_UTR
ENST00000367135.8 3_prime_UTR
Scores
1
15
Clinical Significance
Conservation
PhyloP100: -0.868
Genes affected
SLC26A9 (HGNC:14469): (solute carrier family 26 member 9) This gene is one member of a family of sulfate/anion transporter genes. Family members are well conserved in their genomic (number and size of exons) and protein (aa length among species) structures yet have markedly different tissue expression patterns. The product of this gene is a highly selective chloride ion channel regulated by WNK kinases. Alternative splicing results in multiple transcript variants encoding differing isoforms.[provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.060415834).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A9 | NM_052934.4 | c.*194G>A | 3_prime_UTR_variant | 21/21 | ENST00000367135.8 | NP_443166.1 | ||
SLC26A9 | NM_134325.3 | c.2393G>A | p.Gly798Glu | missense_variant | 22/22 | NP_599152.2 | ||
SLC26A9 | XM_011509121.3 | c.*194G>A | 3_prime_UTR_variant | 20/20 | XP_011507423.1 | |||
SLC26A9 | XM_011509122.3 | c.*194G>A | 3_prime_UTR_variant | 18/18 | XP_011507424.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A9 | ENST00000340781.8 | c.2393G>A | p.Gly798Glu | missense_variant | 21/21 | 1 | ENSP00000341682 | |||
SLC26A9 | ENST00000367135.8 | c.*194G>A | 3_prime_UTR_variant | 21/21 | 1 | NM_052934.4 | ENSP00000356103 | P1 | ||
SLC26A9 | ENST00000367134.2 | c.2393G>A | p.Gly798Glu | missense_variant | 22/22 | 5 | ENSP00000356102 | |||
SLC26A9 | ENST00000491127.5 | n.1954G>A | non_coding_transcript_exon_variant | 13/13 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249636Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134930
GnomAD3 exomes
AF:
AC:
3
AN:
249636
Hom.:
AF XY:
AC XY:
1
AN XY:
134930
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460436Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726246
GnomAD4 exome
AF:
AC:
10
AN:
1460436
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
726246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.2393G>A (p.G798E) alteration is located in exon 22 (coding exon 21) of the SLC26A9 gene. This alteration results from a G to A substitution at nucleotide position 2393, causing the glycine (G) at amino acid position 798 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Pathogenic
D;D
Sift4G
Benign
T;T
Vest4
MutPred
Loss of helix (P = 0.0104);Loss of helix (P = 0.0104);
MVP
MPC
0.18
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at